WhatsApp

Stopping Immunotherapy Due to Side Effects May Not Harm Survival in Kidney Cancer

You are here >> Home > Latest Updates >Kidney Cancer> Stopping Immunotherapy…

Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study).DOI 10.1002ijc.70228

Immunotherapy has changed how doctors treat advanced kidney cancer (renal cell carcinoma). These medicines help the immune system recognize and attack cancer cells. But sometimes patients must stop treatment because of strong side effects.

A large international study looked at more than 1,000 patients with advanced kidney cancer treated with modern immunotherapy combinations.

Researchers wanted to know what happens when patients stop immunotherapy because of serious side effects.
About 185 patients stopped treatment early due to toxicity, while most continued therapy. The encouraging news is that overall survival was similar between patients who stopped treatment and those who continued.
However, timing mattered. Patients who stopped treatment within the first three months tended to have worse outcomes than those who stopped later. This suggests that receiving immunotherapy for at least several months may be important for its full benefit.

These findings are reassuring for patients who experience serious side effects. If treatment must be stopped, it does not necessarily mean the therapy has failed. Doctors can still manage the disease using other treatments or monitoring strategies.

The study highlights the importance of balancing treatment effectiveness with safety and quality of life when using immunotherapy.

Rate this post
dr swati shah - uro & gynec cancer surgeon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.